What is NuSkin Enterprises's debt issued (note 13)?

NuSkin Enterprises (NUS) reported debt issued (note 13) of $225M in Q1 2026.

What is the long-term trend for NuSkin Enterprises's debt issued (note 13)?

Over 2 years (2021 to 2025), NuSkin Enterprises's debt issued (note 13) has grown at a -40.4% compound annual growth rate (CAGR), from $155M to $55M.

NuSkin Enterprises NUS Debt issued (Note 13)

Debt issued (Note 13) at other companies

TFX

TeleflexTFX

$0-100%

Schneider NationalSNDR

$0-100%

NWN

Northwest NaturalNWN

$0-100%

MGP IngredientsMGPI

$10M—

AIR

Air TAIRT

$10.05M+37,122%

Equitable HoldingsEQH

$0-100%

Other financials

Income statement

See full

Revenue$320.6M-12.0%

Gross profit$214.5M-13.2%

Operating income$4.0M+141%

Net income$1.8M-98.3%

EPS (diluted)$0.04-98.1%

Balance sheet

See full

Cash & equivalents$198.7M-2.5%

Total debt$303.6M-8.2%

Total equity$794.1M+5.3%

Total assets$1.4B-1.1%

Cash flow

See full

Operating cash flow-$3.9M-1,107%

CapEx$13.7M+1.0%

Free cash flow-$17.6M-33.6%

Valuation

See full

Market cap$256.35M-38.2%

Where this comes from

Reported directly by NuSkin Enterprises in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfLongTermDebt.

The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about NuSkin Enterprises's debt issued (note 13).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NuSkin Enterprises's debt issued (note 13)?: NuSkin Enterprises (NUS) reported debt issued (note 13) of $225M in Q1 2026.
What is the long-term trend for NuSkin Enterprises's debt issued (note 13)?: Over 2 years (2021 to 2025), NuSkin Enterprises's debt issued (note 13) has grown at a -40.4% compound annual growth rate (CAGR), from $155M to $55M.